Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells
Conclusion: These data serve as proof of principle that Kv1.3 inhibitors kills GBM cells, but drugs that actin vivo against glioblastoma must be developed to translate these findingsin vivo.Neurosignals 2017;25:26 –38
Source: Neurosignals - Category: Neurology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Mitochondria | Neurology | Potassium | Study | USA Health